Abstract
ObjectivesWhile glucocorticoid (GC) treatment initiated for COVID-19 reduces mortality, it is unclear whether GC treatment prior to COVID-19 affects mortality. Long-term GC use raises infection and thromboembolic risks. We investigated...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have